InvestorsHub Logo
Followers 23
Posts 1671
Boards Moderated 0
Alias Born 09/04/2009

Re: None

Saturday, 01/08/2011 12:49:09 PM

Saturday, January 08, 2011 12:49:09 PM

Post# of 29254
"Roche's rituximab loses patent protection in 2012. Spectrum said the drug saw sales of $5.6 billion in 2009."

""I don't think they need to capture a significant portion of the $5.6 billion rituximab market for them to get a substantial return on their investment," Zavoico said."


http://www.reuters.com/article/idUSSGE70408W20110105